IVD Regulatory Consulting Services

Cisema offers specialized services for international in vitro diagnostic (IVD) manufacturers targeting the Chinese, Hong Kong, and ASEAN markets, including Malaysia, Vietnam, Singapore, Thailand, Indonesia, and the Philippines.

With deep knowledge of regional requirements and local authority expectations, our multi-lingual teams across Europe and Asia help you navigate complex regulatory pathways with confidence. Our experience enables us to expertly guide clients through the Asia-Pacific regional regulatory landscapes and leverage worldwide standards for market expansion.

IVD Regulatory Services - Cisema
IVD Regulatory Consulting Services
IVD Registration Applications

Our services cover every stage of the regulatory process: from product classification, local type testing if required, and dossier preparation to NMPA registration in China, MDACS listings in Hong Kong, and regulatory submissions across ASEAN member states. We also support clinical trial exemptions, QMS documentation, labeling conformity, and post-market surveillance, ensuring a smooth market launch and ongoing compliance. Our in-house team and resources, including dedicated consultants and infrastructure, further strengthen our ability to support regulatory consulting and product development.

Whether you’re developing molecular diagnostics, immunoassays, or software-driven IVDs, Cisema delivers tailored support for your product type. We work with startups and multinational leaders alike, offering hands-on guidance and regulatory strategy insight throughout the registration process.

In addition to IVDs, our integrated services extend to related sectors such as medical devices, pharmaceuticals, health foods, cosmetics, and veterinary products, providing a single, reliable partner for your regulatory needs across the Asia-Pacific region. Clients have the opportunity to collaborate with Cisema for strategic guidance and feedback at every stage of the regulatory process, maximizing the potential for successful product development and regulatory approval. Our support is dedicated to ensuring the success of your product’s journey from development to market authorization.

From IVD Classification to Post-Market Surveillance

The first step in the process is classification. Our regulatory experts will assist you through the classification process by conducting a thorough review of your device’s intended use, design, and materials, to help determine the appropriate risk management class and ensure that all applicable regulations are met. This expertise is vital for ensuring compliance and avoiding costly missteps that could delay market entry. With the right classification strategy, companies can confidently proceed with the necessary submissions and approvals, knowing they are aligned with regulatory expectations and requirements.

Achieving market approval is only the beginning of an IVD's regulatory journey. Post-market support and surveillance are critical processes that ensure the ongoing safety, quality, and effectiveness of IVDs once they are in use.

Our teams assist companies in developing and executing comprehensive PMS plans tailored to their IVDs and target markets. This includes establishing quality management systems, monitoring IVD performance, and conducting regular reviews to identify and address any emerging issues. By ensuring that all necessary processes and systems are in place, our consultants help companies maintain compliance with requirements and uphold the highest standards of patient safety. Ongoing post-market support not only protects your business from regulatory risks but also reinforces your commitment to delivering safe and effective products to the market.

Specialized expertise in IVD regulatory strategy

Discover Our IVD Consulting Services

Whether you’re just starting out or are a blue-chip, access our wide range of solutions and valuable insights to help your business thrive in China and across Asia Pacific. We support clients with project-based regulatory consulting for specific product registrations or submissions, helping you navigate the regulatory challenges of market entry. Our team also emphasizes the importance of technology in IVD development and supports innovative technologies through the regulatory process.

NMPA IVD Approvals

We guide you through every step of the China IVD registration and filing process. We conduct thorough regulatory assessments to determine device classification and compliance requirements, ensuring you meet all NMPA standards.

NMPA Legal Agent

We are your authorized representative in China, and fulfill your NMPA registrations, filings and renewal applications as well as ensuring compliance with quality and PMS requirements.

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.

China IVD Quality Compliance

We help you achieve and ensure ongoing quality assurance and compliance with Chinese requirements. We support you in managing risk and quality management systems to meet Chinese regulatory standards. Our experts prepare and assist you for official NMPA inspections.

Drug Device Combination Products

We assist with the classification, authorization, and compliance of combination products in China, whether drug or device led. We provide expert guidance for borderline products, addressing the complexity of their classification.

IVD PMS & Vigilance

The NMPA is placing greater focus on PMS such as more in-China sampling inspections and regular standard changes.Our specialist PMS team means you stay up to date with the many aspects of compliance.

IVD Regulatory Affairs Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, we have a variety of solutions to meet your needs. We can support multiple projects simultaneously, ensuring efficient management and compliance.

NMPA IVD Type Testing

Our on-site test engineers coordinate and supervise type tests of your IVDs in NMPA-accredited laboratories. We have experience working with notified bodies, especially for high-risk or complex devices, to ensure all regulatory requirements are met.

Discover Our Hong Kong IVD Consulting Services

Our Hong Kong In-vitro Diagnostic Consulting Services provide targeted support to help you meet regulatory requirements and launch your products with confidence.

Hong Kong Local 
Responsible Person

We act as your designated Local Responsible Person (LRP), fulfilling listing and PMS obligations under MDACS.

Hong Kong IVD Registration

We support you through every stage of the Hong Kong IVD Listing process. From classification to handling regulatory requirements, we make the process as smooth as possible.

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, our team of consultants has a variety of solutions to meet your needs.

Discover Our Other IVD Consulting Services

Our local regulatory experts throughout ASEAN provide dedicated IVD Consulting Services to help you develop optimized regulatory strategies to meet requirements and confidently launch your products. We help clients implement best regulatory and quality practices, including good manufacturing practices and quality management practices, to ensure successful market entry in ASEAN countries:

Local Responsible Person

We act as your designated Local Responsible Person (LRP), fulfilling registration, post-market activities and QMS compliance. We also support clients with risk management processes, such as those aligned with ISO 14971, to meet ASEAN regulatory requirements.

IVD Market Approvals

We support you through every stage of the approval process. From classification to handling regulatory requirements, including risk management and adherence to best practices, we make the process as smooth as possible.

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, our team of consultants has a variety of regulatory support solutions to meet your needs.

Other Markets We Support for Medical Device & IVD Registration

Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

Malaysia

Vietnam

Singapore

Thailand

Indonesia

Philippines

Taiwan

Useful Articles

View More

China Medical Device and IVD Registration FAQs: What Foreign Manufacturers Need to Know About NMPA Requirements

Get answers to common China medical device and IVD registration questions, from NMPA classification rules to testing and renewal requirements.

April 15, 2026
China Medical Device and IVD Registration FAQs: What Foreign Manufacturers Need to Know About NMPA Requirements
China Medical Device and IVD Registration FAQs: What Foreign Manufacturers Need to Know About NMPA Requirements

China IVD Risk Classification Explained: How NMPA Class Shapes Registration Pathways

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

April 15, 2026
China IVD Risk Classification Explained: How NMPA Class Shapes Registration Pathways
China IVD Risk Classification Explained: How NMPA Class Shapes Registration Pathways
Previous
Previous

Other Industries We Support

In addition to IVDs, we offer consulting services across regulated industries including medical devices, pharmaceuticals, biopharma, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Medical Devices

Pharmaceuticals

Biotech

Cosmetics

Health Foods & Supplements

Veterinary Medicines & Products

Industrial Goods & Consumer Products

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

Cisema supported Inox Torres Group in successfully renewing its China SELO license for Level A2 pressure vessels through expert audit preparation and regulatory guidance.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More

China NMPA Issues 2026 Medical Device Industry Standards Development and Revision Plan

China’s National Medical Products Administration has issued its 2026 medical device standards plan, introducing 80+ new and revised standards

March 31, 2026
China NMPA Issues 2026 Medical Device Industry Standards Development and Revision Plan

Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Learn how to register medical devices in Indonesia, including Authorized Representative rules, classification, dossiers, timelines, and fees.

March 30, 2026
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Medical Devices in China: A Regulatory Glossary for NMPA Compliance

Practical China medical device glossary explaining NMPA terms, with clear comparisons to US FDA and EU MDR terminology.

March 18, 2026
Medical Devices in China: A Regulatory Glossary for NMPA Compliance
Medical Devices in China: A Regulatory Glossary for NMPA Compliance

China NMPA Clears 104 Innovative Medical Devices for Special Review in 2025

Learn about the 104 products China’s NMPA admitted into the Special Review Procedure for Innovative Medical Devices in 2025.

March 18, 2026
China NMPA Clears 104 Innovative Medical Devices for Special Review in 2025
China NMPA Clears 104 Innovative Medical Devices for Special Review in 2025

Hong Kong Launches Pre-NDA Meetings Under the “1+” Drug Registration Mechanism

Hong Kong’s Department of Health introduces Pre-NDA meetings to streamline new drug registrations under the “1+” mechanism.

April 15, 2026
Hong Kong Launches Pre-NDA Meetings Under the “1+” Drug Registration Mechanism
Hong Kong Launches Pre-NDA Meetings Under the “1+” Drug Registration Mechanism

Hong Kong DH Mandates Medical Device Listing for Public Procurement by March 2026

The Department of Health has mandated MDACS listing for public procurement eligibility — see which devices are affected and how to prepare.

April 15, 2026
Hong Kong DH Mandates Medical Device Listing for Public Procurement by March 2026
Hong Kong DH Mandates Medical Device Listing for Public Procurement by March 2026
Previous
Previous

Get in Touch with Our IVD Regulatory Consultants

And discover how we can support you in achieving approval for your in-vitro diagnostic with regulatory authorities in China, Hong Kong, ASEAN Taiwan.

Request Proposal